0
JAMA Patient Page |

Amyotrophic Lateral Sclerosis FREE

John L. Zeller, MD, PhD, Writer; Cassio Lynm, MA, Illustrator; Richard M. Glass, MD, Editor
JAMA. 2007;298(2):248. doi:10.1001/jama.298.2.248.
Text Size: A A A
Published online

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig disease, involves progressive loss of motor neurons (a type of nerve cell controlling muscle movements) in the brain and spinal cord. ALS is a progressive, disabling, and ultimately fatal disease of unknown cause. Walking, speaking, swallowing, breathing, and other basic functions become impaired with time. About 30 000 Americans currently have ALS. The yearly incidence rate is 1 to 2 new cases per 100 000 individuals. The disease is commonly discovered during middle age and affects more men than women. The July 11, 2007, issue of JAMA includes an article discussing the diagnosis of ALS and recommendations for palliative (supportive) care.

SYMPTOMS

It is estimated that more than 50% of motor neurons are lost before symptoms such as muscle weakness become apparent.

  • Gradual muscle weakness and wasting in arms and legs

  • Muscle fasciculations (twitches visible in muscles)

  • Difficulty with swallowing, speaking, and breathing

  • Muscle stiffness, bodily pains, and cramps, especially at night

Respiratory failure is the usual cause of death in ALS. Other causes include pneumonia. In most cases, death occurs within 3 to 6 years after symptoms begin, although some individuals with ALS live for many years, even decades.

DIAGNOSIS

Diagnosis is based on a careful medical history, physical examination, and laboratory tests. Electromyograms (EMGs)—nerve conduction studies that evaluate nerve and muscle function—are the key tests. Other tests may include blood tests and neuroimaging studies such as CT or MRI scans of the brain and spinal cord. Molecular testing, cerebrospinal fluid tests, or muscle biopsy may be necessary.

TREATMENT

  • Physical, occupational, and speech therapies can assist in daily functioning.

  • Riluzole is the only medication approved for the treatment of ALS. It may prolong survival by a few months.

  • Other medications may relieve symptoms such as muscle pain, cramping, drooling, spasms, and fatigue.

SUPPORTIVE CARE

  • Appropriate exercises to help maintain mobility, strength, and energy

  • Changes in diet to minimize episodes of choking and ensure adequate nutrition

  • Effective use of assistive devices and braces such as neck collar, foot brace, cane, walker, or wheelchair

  • Ramps, handrails, raised toilet seat, shower seat

  • Erasable writing tablets or voice amplifiers and computers to help communication

  • A noninvasive ventilator (breathing machine) may be important to support breathing

The progressive, disabling nature of ALS and the fact that there is no cure make it a difficult disease to manage. In addition to medical care, patients need emotional support from family, friends, doctors, and caregivers.

FOR MORE INFORMATION

INFORM YOURSELF

To find this and previous JAMA Patient Pages, go to the Patient Page link on JAMA's Web site at http://www.jama.com. Many are available in English and Spanish.

Sources: Muscular Dystrophy Association, Amyotrophic Lateral Sclerosis Association

The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. To purchase bulk reprints, call 203/259-8724.

TOPIC: NEUROLOGICAL DISEASE

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles